| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5686555 | The Journal of Urology | 2017 | 29 Pages |
Abstract
Patients with sarcomatoid renal cell carcinoma still have poor prognosis with no clear long-term benefit of targeted therapy. This underscores the need to develop more effective systemic therapies for these patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sarp K. Keskin, Pavlos Msaouel, Kenneth R. Hess, Kai-Jie Yu, Surena F. Matin, Kanishka Sircar, Pheroze Tamboli, Eric Jonasch, Christopher G. Wood, Jose A. Karam, Nizar M. Tannir,